About Earli
Earli is a company based in San Francisco (United States) founded in 2018 by Sam Gambhir, David Suhy, and Cyriac Roeding. It operates as a HealthTech. Earli has raised $40 million across 2 funding rounds from investors including Accenture, Khosla Ventures and Perceptive Advisors. The company has 38 employees as of December 31, 2022. Earli offers products and services including Synthetic Biomarkers and Programmable Genetic Constructs. Earli operates in a competitive market with competitors including GRAIL, Color, Delfi Diagnostics, RainDance and Foresight Diagnostics, among others.
- Headquarter San Francisco, United States
- Employees 38 as on 31 Dec, 2022
- Founders Sam Gambhir, David Suhy, Cyriac Roeding
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Earli Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$40 M (USD)
in 2 rounds
-
Latest Funding Round
-
Investors
Accenture
& 9 more
-
Employee Count
38
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Earli
Earli offers a comprehensive portfolio of products and services, including Synthetic Biomarkers and Programmable Genetic Constructs. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Synthetic biomarkers are used for early cancer detection.
Genetic constructs are designed to target cancer cells.
Unlock access to complete
Unlock access to complete
Funding Insights of Earli
Earli has successfully raised a total of $40M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
-
First Round
First Round
(12 Jan 2021)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2024 | Amount | Series A - Earli | Valuation | Accenture |
|
| Jan, 2021 | Amount | Series A - Earli | Valuation | Khosla Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Earli
Earli has secured backing from 10 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Accenture, Khosla Ventures and Perceptive Advisors. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are funded by this venture capital firm.
|
Founded Year | Domain | Location | |
|
Health-tech companies are targeted for venture capital investments.
|
Founded Year | Domain | Location | |
|
Investing in Life Sciences sectors like Healthcare and Biotechnology.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Earli
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Earli
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Earli Comparisons
Competitors of Earli
Earli operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GRAIL, Color, Delfi Diagnostics, RainDance and Foresight Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Circulating tumor DNA is screened for early cancer detection.
|
|
| domain | founded_year | HQ Location |
Cancer care is delivered through a virtual clinic by Color.
|
|
| domain | founded_year | HQ Location |
Provider of DNA sequencing for cancer detection
|
|
| domain | founded_year | HQ Location |
Developer of nucleic acid detection and quantification systems
|
|
| domain | founded_year | HQ Location |
Minimally invasive liquid biopsy tests for cancer detection are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Earli
Frequently Asked Questions about Earli
When was Earli founded?
Earli was founded in 2018 and raised its 1st funding round 3 years after it was founded.
Where is Earli located?
Earli is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Who is the current CEO of Earli?
Cyriac Roeding is the current CEO of Earli. They have also founded this company.
Is Earli a funded company?
Earli is a funded company, having raised a total of $40M across 2 funding rounds to date. The company's 1st funding round was a Series A of $40M, raised on Jan 12, 2021.
How many employees does Earli have?
As of Dec 31, 2022, the latest employee count at Earli is 38.
What does Earli do?
Earli is engaged in developing innovative solutions for early cancer detection and therapy. Programmable genetic constructs are created to activate only in cancer cells, forcing them to produce therapies that lead to self-destruction. Synthetic biomarkers are utilized to identify hidden cancer at its earliest stages. The company operates within the biotechnology sector, addressing critical challenges in cancer diagnostics and treatment. Partnerships with organizations like Accenture are established to advance their mission. Recognition as a global innovator by the World Economic Forum is received, highlighting their impact in the healthcare industry.
Who are the top competitors of Earli?
Earli's top competitors include GRAIL, UDX and Delfi Diagnostics.
What products or services does Earli offer?
Earli offers Synthetic Biomarkers and Programmable Genetic Constructs.
Who are Earli's investors?
Earli has 10 investors. Key investors include Accenture, Khosla Ventures, Perceptive Advisors, Casdin Capital, and Andreessen Horowitz.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.